Search results
Showing results for
Oxford University has been ranked as the world's best institution for medical and health teaching and research in the Times Higher Education World University Rankings for the eighth consecutive year. This ranking is based on criteria measuring teaching, research, industry income, international outlook and citations. It was noted that both research and clinical trials are supported by our network of international research units in Africa and Asia.
Congratulations to our new Associate Professors 2026
5 May 2026
Our heartfelt congratulations to Charles N Agoti from KWTRP, to Cindy Chu, Liz Batty and Tom Peto from MORU, and to Marc Choisy from OUCRU who have been awarded Associate Professorships
New study improves the prediction of life-threatening infection in children across South and Southeast Asia
5 May 2026
A new approach to paediatric triage could prevent thousands of deaths and unnecessary referrals in resource-constrained and conflict-affected settings, say researchers in a study published on 29 April 2026 in Nature Medicine.
IHTM students celebrate end of exams
30 April 2026
Celebrating the 2025/26 IHTM cohort as they complete final exams and prepare for research placements around the world
Climate Change and Health are Gendered: How Women Workers in Jakarta Adapted in Climate Change
29 April 2026
OUCRU Indonesia co-designs Climate and Health Engagement Project named Panas, Polusi Udara, dan Perempuan Pekerja (Urban Island Heat, Air Polution and Women Workers) or (P4 project) which also become the first engagement specific collaborative study with women workers in Jakarta and fully funded by WHO.
30 years of MORU research in Rickettsioses featured in ESCMID 2026 keynote
28 April 2026
MORU was well represented at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) 2026 conference, held from 17-21 April in Munich.
From Kilifi to the World: Rethinking Malaria Control Through Three Decades of Research
25 April 2026
Since 1995, the KEMRI–Wellcome Trust Research Programme has quietly reshaped the global fight against malaria, not through a single breakthrough, but through a sustained commitment to evidence, context and people. Its work offers a powerful lesson: defeating malaria is not just about tools, but about understanding systems, adapting strategies and investing in local science. This is a thought leadership piece by Professor Isabella Oyier, Head of Bioscience, KEMRI-Wellcome
Expert Comment: World Malaria Day 2026 - Malaria vs the Data Collective
25 April 2026
Millions of African children receive preventative antimalarial drugs during the yearly malaria ‘high season’, a strategy aimed at reducing the annual toll of 600,000 malaria deaths worldwide – most of these deaths are children in Sub-Saharan Africa. IDDO DPhil student Dhruv Darji is using the collective power of data to find ways to make this preventative treatment better, including understanding interactions with the many real-world factors that health policy makers grapple with.
Innovative housing design cools homes, saves lives in Africa
22 April 2026
Simple improvements in housing can have a profound impact on public health in sub-Saharan Africa, say researchers who designed Star Home, a novel double-story house that provides an insect-proof, cleaner, cooler and smoke-free environment with reliable water and sanitation in Tanzania.
OUCRU joins WHO Coronavirus Network
17 April 2026
OUCRU, hosted by the Hospital for Tropical Diseases (HTD) in Ho Chi Minh City, Vietnam, has joined the World Health Organisation (WHO) Coronavirus Network (CoViNet), a global network to detect and monitor coronaviruses of public health importance.
From MODRA to Wellcome Sanger Fellowship: Dr Le Thanh Hoang Nhat reflects on Growth and Connection
13 April 2026
Dr Nhat, a MODRA alumnus, has been awarded a Wellcome Sanger Fellowship. Reflecting on his journey, he highlights how mentorship, regional collaboration and focused training through MODRA helped shape a competitive research proposal and strengthen his direction as an independent researcher.
Reimagining community mental health in Kenya through the 'Nyumba Kumi' model
13 April 2026
A new community-based mental health approach in Kenya draws on the Nyumba Kumi model, where trusted local elders support small household groups. Combining cultural practice with psychological research, the project aims to address limited access to care by enabling early intervention and prevention, empowering communities to take a leading role in improving mental well-being.
Integration of Infection Prevention and Control into the Antimicrobial Stewardship Programme – 60HN ASPARNet
10 April 2026
The study titled “Evaluating Antimicrobial Stewardship strategies and capacity building through Participatory Action Research and a Network approach in Vietnam” (60HN – ASPARNet) continues to implement key activities to promote AMS programmes across hospitals participating in the network.
GRAM to host 27th and 29th April webinar on AMR insights for policy
8 April 2026
The Global Research on Antimicrobial Resistance (GRAM) Project is inviting global AMR stakeholders to attend its 27th and 29th April webinar, ‘Information to action: Antimicrobial resistance insights for policy’. Led by GRAM partners at IHME, the session will explore successful interventions to combat AMR, and conclude with a demonstration of data tools that may assist policymakers and researchers in quantifying the impact of interventions targeting AMR.
Study brings together prognostic models for visceral leishmaniasis outcomes
7 April 2026
A BMJ Public Health review by IDDO researchers analysed 12 prognostic models for visceral leishmaniasis, identifying significant gaps and high risk of bias. Developed mainly in Brazil and East Africa, these models lack applicability in high-burden regions like the Indian subcontinent. The findings support improved model development and better-informed clinical decision-making.
IHTM students take policy briefs to UK Parliament
31 March 2026
11th cohort of students present to Parliament on global health's most pressing challenges
New £5 million Wellcome Discovery Award to transform treatment for tuberculous meningitis
24 March 2026
Tuberculous meningitis remains highly lethal despite standard treatment, and recent trials show current antibiotic and corticosteroid approaches are not good enough. A new international research programme, funded by Wellcome, aims to develop improved therapies by studying disease mechanisms, testing novel drugs and identifying biomarkers, aiming to guide safer, more effective treatment and reduce global deaths.
Championing Ethical Research: Dorcas Kamuya on Community, Science, and Women in Leadership
23 March 2026
Dorcas Kamuya’s journey highlights the impact of ethical, community-centred research. From rural Kenya to scientific leadership, she champions equity, mentorship, and inclusive research practices. Her work ensures that science respects community voices while advancing health systems, inspiring the next generation of women in research.
Advancing Epilepsy Care in Africa: Insights from the EPInA Dissemination Meeting in Nairobi
23 March 2026
The EPInA project (Epilepsy Pathway Innovations in Africa) convened stakeholders in Nairobi to advance epilepsy care across Africa, supporting WHO’s Intersectoral Global Action Plan framework. Through community engagement and digital innovation, the initiative improves diagnosis, treatment and stigma reduction. The meeting emphasised translating evidence into action, strengthening health systems, and expanding access to equitable neurological care.
Strengthening intensive care capacity in Vietnam through international training
20 March 2026
OUCRU held its annual intensive care training for healthcare workers on 12–13 March 2026 in Ho Chi Minh City. The two-day programme brought together specialists from the UK and Vietnam to share the latest knowledge and skills in critical care medicine.
Oxford and Serum Institute of India sign IP license agreement to advance NipahB vaccine candidate
17 March 2026
The University of Oxford and Serum Institute of India Pvt. Ltd. (SII), a Cyrus Poonawalla Group company and the world’s largest vaccine manufacturer, have signed an Intellectual Property license agreement to advance the development and manufacture of the ChAdOx1 NipahB vaccine candidate. Professor Brian Angus is Chief Investigator of the trial.